SDI Limited Provides Earnings Guidance for the Six Months Ended 31 December 2017
January 04, 2018 at 10:22 pm
Share
SDI Limited provided earnings guidance for the six months ended 31 December 2017. The company expected sales to be AUD 33.6 million, down 2.2% on the previous corresponding period of AUD 34.4 million. When adjusted for currency movements, sales are expected to be down 1.5%. Despite a strong performance in Aesthetics sales (40% of Australian dollar sales), which recorded growth in Australian dollars of 8.2%, the overall Australian sales were impacted by weaker than expected Amalgam sales, which fell 15.3% in Australian dollars for the half year. The company expected after tax profit to be in the range of AUD 1.0 million to AUD 1.3 million, compared
with AUD 2.0 million for the same period last year. Due to the Company's substantial natural hedging, currency movements are not expected to have a material impact on the result.
SDI Limited is an Australia-based dental technology company that is involved in the research and development, manufacturing, and marketing of specialist dental materials. The principal activities of the Company include manufacture and distribution of dental restorative materials, tooth whitening systems, other dental materials and product research and development. Its segments include Australia, Europe, USA, and Brazil. The Australia segments include SDI Limited. The Europe segment include SDI Germany GmbH (Germany) and SDI Dental Innovations Limited (United Kingdom). The USA segment includes SDI (North America), Inc. The Brazil segment includes SDI Brasil Industria e Comercio Ltda and SDI Holdings Do Brazil Ltda. Its product categories include accessories, adhesives, alloys, cements, composites, equipment, etchants, glass ionomers, sealants, and tooth whitening. Its products are sold through distributors and retailers in over 100 countries throughout the world.
SDI LIMITED 
